Boston Scientific (BSX), Philips (PHG) Enter Imaging Equipment Sales Agreement
Get Alerts BSX Hot Sheet
Join SI Premium – FREE
Boston Scientific Corporation (NYSE: BSX) and Royal Philips Electronics (NYSE: PHG) announced a collaboration enabling Philips to sell Boston Scientific Imaging equipment in connection with its Allura Xper catheterization (cath) lab systems in territories throughout the world.
The Boston Scientific iLabâ„¢ Ultrasound Imaging System serves as a versatile platform for utilizing Boston Scientific's imaging catheters. The iLab System features exceptional image quality and allows physicians the ability to choose from a variety of imaging catheters for coronary, peripheral and intracardiac applications. The iLab System is compatible and can be integrated with all major X-ray systems including the Philips Allura Xper system. This agreement gives Philips the ability to offer customers an integrated imaging solution that is compatible with current and next-generation Boston Scientific imaging catheters.
The Boston Scientific iLabâ„¢ Ultrasound Imaging System serves as a versatile platform for utilizing Boston Scientific's imaging catheters. The iLab System features exceptional image quality and allows physicians the ability to choose from a variety of imaging catheters for coronary, peripheral and intracardiac applications. The iLab System is compatible and can be integrated with all major X-ray systems including the Philips Allura Xper system. This agreement gives Philips the ability to offer customers an integrated imaging solution that is compatible with current and next-generation Boston Scientific imaging catheters.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Akeso's ivonescimab beats durvalumab in biliary tract cancer trial
- TD Cowen Reiterates Buy Rating on Boston Scientific (BSX), sees creative setup for 2027
- First Majestic files NI 43-101 technical report for Los Gatos mine
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share